ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 53 filers reported holding ADMA BIOLOGICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -100.0% | 1,693 | -81.3% | 0.00% | – |
| Q2 2022 | $17,000 | +21.4% | 9,070 | +11.8% | 0.00% | – |
| Q1 2022 | $14,000 | +1300.0% | 8,113 | +472.5% | 0.00% | – |
| Q4 2021 | $1,000 | -99.7% | 1,417 | -99.2% | 0.00% | – |
| Q3 2021 | $291,000 | -0.7% | 183,196 | 0.0% | 0.00% | – |
| Q2 2021 | $293,000 | -2.0% | 183,196 | +7.5% | 0.00% | -100.0% |
| Q1 2021 | $299,000 | – | 170,364 | +41050.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 414 | -99.6% | 0.00% | -100.0% |
| Q2 2020 | $335,000 | +335.1% | 114,363 | +327.6% | 0.00% | – |
| Q1 2020 | $77,000 | +285.0% | 26,748 | +434.7% | 0.00% | – |
| Q4 2019 | $20,000 | – | 5,002 | +1661.3% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 284 | -95.0% | 0.00% | – |
| Q3 2018 | $35,000 | – | 5,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
| Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
| Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
| AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
| Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
| Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
| EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
| Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
| EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |